FDA Adverse Event Injury Summary report: N

2.0 LACTOSORB SYSTEM 2.0 X 7 MM LACTOSORB SCREW

MDR report key: 7178270 · Received January 10, 2018

Report

Report Number
0001032347-2018-00018
Event Type
Injury
Date Received
January 10, 2018
Date of Event
December 1, 2017
Report Date
August 6, 2018
Manufacturer
BIOMET MICROFIXATION
Product Code
HRS
PMA / PMN Number
PK971870
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. THERE WAS A REVISION, THEREFORE THE COMPLAINT IS CONSIDERED CONFIRMED. NO FURTHER INFORMATION WAS PROVIDED TO EXPLAIN THE MEANING OF "COMPLICATION" IN THE COMPLAINT REPORT, AND VISUAL INSPECTION AND FUNCTIONAL TESTING COULD NOT BE PERFORMED DUE TO THE PARTS NOT BEING RETURNED. HOWEVER, OSTEOLYSIS, OR BONE RESORPTION WAS REPORTED TO HAVE BEEN OBSERVED AT THE ZYGOMATICOALVEOLAR LINE. ALSO, THE PATIENT INITIALLY HAD A LE-FORT 1 OSTEOTOMY PERFORMED ON (B)(6) 2017, WHICH IS DONE TO CORRECT FACIAL DEFORMITIES. THIS INFORMATION INDICATES THAT THE MOST LIKELY UNDERLYING CAUSE OF THE COMPLAINT IS PATIENT CONDITION. THE INSTRUCTIONS FOR USE (IFU) HAS THE FOLLOWING INFORMATION FOR WHICH THE PRODUCT SHOULD NOT BE USED UNDER THE SECTION TITLED CONTRAINDICATIONS: PATIENT CONDITIONS INCLUDING, BLOOD SUPPLY LIMITATIONS, INSUFFICIENT QUANTITY OR QUALITY OF BONE STOCK OR LATENT INFECTION. DEVICE HISTORY RECORD (DHR) REVIEW WAS UNABLE TO BE PERFORMED AS THE LOT NUMBERS OF THE DEVICES INVOLVED IN THE EVENT ARE UNKNOWN. INVESTIGATION RESULTS CONCLUDED THAT THE REPORTED EVENT WAS DUE TO PATIENT CONDITION. A SUMMARY OF THE INVESTIGATION HAS BEEN SENT TO THE COMPLAINANT. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001032347-2018-00016-2 AND 0001032347-2018-00017-2.

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY CORRECTED AND ADDITIONAL INFORMATION. DATE OF EVENT: THE EVENT OCCURRED SOMETIME IN (B)(6) 2018. (B)(4). PMA/510(K) NUMBER: UPDATED FROM K002083 TO K971870. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001032347-2018-00016-3 AND 0001032347-2018-00017-3.

Description of Event or Problem · 0

THE DISTRIBUTOR PROVIDED ADDITIONAL INFORMATION. ALTHOUGH IT WAS REPORTED THAT THERE WAS REVISION, THERE WAS NO REVISION AT THE TIME. THE MAXILLARY SINUSITIS WAS OBSERVED IN (B)(6) 2018 AND THE SURGEON PERFORMED CLEANING AND CURETTAGE TO THE PATIENT AS THE TREATMENT, NOT REVISION. AFTER THAT, THE PATIENT HAVE RECOVERED WELL BUT THE REVISION WAS PERFORMED TO REMOVE THE REMAINING PRODUCTS INSIDE OF THE PATIENT'S BODY ON (B)(6) 2018 BECAUSE OSTEOLYSIS WAS OBSERVED AGAIN; SEE ASSOCIATE REPORTS 0001032347-2018-00492, 0001032347-2018-00493, AND 0001032347-2018-00494.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCT - BIOMET LACTOSORB L-PLATE RIGHT- REGULAR CATALOG #: 915-2101 LOT #: NI, BIOMET LACTOSORB L-PLATE LEFT - REGULAR CATALOG #: 915-2102 LOT #: NI. CONCOMITANT MEDICAL PRODUCT: THERAPY DATE - (B)(6) 2017. (B)(6). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, THE REVISION HAS NOT YET OCCURRED. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001032347-2018-00016 AND 0001032347-2018-00017.

Additional Manufacturer Narrative · 1

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001032347-2018-00016-1 AND 0001032347-2018-00017-1.

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT HAD A LE-FORT 1 OSTEOTOMY PROCEDURE AND DEVELOPED A COMPLICATION AFTER 8 MONTHS. OSTEOLYSIS WAS OBSERVED AT ZYGOMATICOALVEOLAR LINE. THEREFORE, A REVISION WILL BE SCHEDULED TO REMOVE PRODUCTS. ADDITIONAL INFORMATION WAS REQUESTED, HOWEVER AT THIS TIME THE COMPLICATION EXPERIENCED BY THE PATIENT IS UNKNOWN. NO ADDITIONAL PATIENT CONSEQUENCES WERE REPORTED.

Description of Event or Problem · 1

IT WAS REPORTED THE REVISION OCCURRED, HOWEVER THE DATE IS UNKNOWN. DURING THE REVISION IT WAS IDENTIFIED THE PRODUCTS WERE ABSORBED INTO THE PATIENT'S BODY; THEREFORE NO PRODUCT IS AVAILABLE FOR EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
23561 2.0 LACTOSORB SYSTEM 2.0 X 7 MM LACTOSORB SCREW SCREW, FIXATON, BONE HRS BIOMET MICROFIXATION N/A UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R